R&D Views & Analysis | pharmaphorum

Views & Analysis

Report calls for better work culture in UK research

Create a positive working culture for the UK’s researchers, or watch the country’s standing as an innovation leader crumble, says new report.

Videos

Health Innovators: Teresa Arroyo-Gallego, nQ Medical

In this episode of our Health Innovators series, Paul Tunnah is joined by Teresa Arroyo-Gallego, chief data scientist at artificial intelligence technology company nQ Medical.

Views & Analysis

Inside MoonLake’s raid on Merck KGaA’s inflammatory disease ...

Swiss biotech MoonLake Immunotherapeutics has emerged with what it hopes is one of the hottest drugs in inflammatory diseases, sonelokimab.

Views & Analysis

Where-next-for-patient-centricity-in-pharma

Why relationships are key in rare disease patient engagement

Real-world data is a vital part of rare disease drug development, but to get a true picture of patients’ unmet needs pharma should take a broader view of their lived experiences, says Xperi

Views & Analysis

Tackling diabetes & ALS with cell therapy

Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as Amyotrophic lateral

Views & Analysis

Building a better future for people with rare diseases in all four UK nations

Creating a global life sciences superpower from the lessons ...

It’s time to take what the UK has learnt about the “Holy Trinity” of government, academia, and industry and apply it to creating a “life sciences superpower”, says health secretary Matt Han

Report calls for better work culture in UK research

Health Innovators: Teresa Arroyo-Gallego, nQ Medical

Inside MoonLake’s raid on Merck KGaA’s inflammatory disease ...

Why relationships are key in rare disease patient engagement

Tackling diabetes & ALS with cell therapy

Creating a global life sciences superpower from the lessons ...

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks